Specialized tourniquets designed for untrained first responders are helping civilian emergency care providers in Ukraine stop life-threatening bleeding.
Read MoreThe result of a major multi-departmental and multi-school collaboration, the investment will support the Weil Institute’s unique preclinical critical care lab to advance translational research in critical care over the next 5 years.
Read MoreAmid growing federal concerns regarding "foreign influence" on research activity, some federal agencies have issued statements emphasizing the need for increased transparency with respect to international collaborations. Failure to comply could jeopardize the ability of faculty and the university to receive federal support for research.
Read MoreMichigan Medicine spinoff company receives the funding to commercialize the technology as its first product.
Read MoreFifth Eye Inc. has raised $11.5 million in Series A funding led by Arboretum Ventures and Cultivation Capital. Other participants in the round included MINTS, the direct investing arm of the University of Michigan’s endowment, along with additional capital from previous investors Invest Michigan and 35 private angel investors.
Fifth Eye Press Release: https://fiftheye.com/wp-content/uploads/2019/03/fifth-eye-press-release-final.pdf
Read MoreFifth Eye Inc. raises total venture backing of $11.5M to secure FDA clearance for their first product, Analytic for Hemodynamic Instability!
Fifth Eye Press Release: https://fiftheye.com/wp-content/uploads/2019/03/fifth-eye-press-release-final.pdf
Read MoreFifth Eye Inc. raises $11.5M Series A investment to secure FDA clearance for their first product, Analytic for Hemodynamic Instability!
Fifth Eye Press Release: https://fiftheye.com/wp-content/uploads/2019/03/fifth-eye-press-release-final.pdf
Read MoreMCIRCC’s objective is to transform critical care through innovation, integration, and entrepreneurship. But what does that mean and how is it being done? The MCIRCC Pre-Clinical Operative and Intensive Care Unit was created in February 2013 to embody this objective and has made great strides in high-risk, high-reward pursuits.
Read More